Pakistan faces shortage of 100 life-saving medicines like cancer drugs, morphine
Why This Matters
The shortage of essential medicines in Pakistan highlights the country's vulnerability to healthcare crises, underscoring the need for a more robust and resilient pharmaceutical supply chain. This situation also raises concerns about the accessibility of life-saving treatments, particularly for vulnerable populations. The crisis underscores the importance of effective regulatory frameworks and timely price revisions to ensure the availability of critical medicines.
Pakistan faces a critical shortage of over 100 essential medicines, including life-saving drugs. Delayed price revisions by the Drug Regulatory Authority of Pakistan are disrupting production. Rising costs of raw materials and currency depreciation have impacted manufacturing expenses significantly. This situation is creating space for counterfeit and substandard products in the market. Industry representatives urge the government to approve pending hardship pricing cases immediately.
Curation & Context
This page summarizes a public news report from timesofindia.indiatimes.com. Global News Hub provides the "Why This Matters" takeaway using editorial insights and AI curation to give readers rapid, high-value context before they click through to read the full article.